Search Results 31-40 of 13527 for risksas

  1. https://www.mayoclinic.org/arabic_patient_consumer_video.xml

  2. A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma - Mayo Clinic

    Selumetinib is a drug that works by blocking some enzymes that low grade glioma tumor cells need for their growth. This results in killing tumor cells. Drugs ...

  3. https://www.mayoclinic.org/spanish_patient_consumer_video.xml

  4. A Study to Assess the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment - Mayo Clinic

    The objective of Study M15-991 is to evaluate the efficacy and safety of risankizumab versus placebo during induction therapy in subjects with moderately to ...

  5. Long Term Follow-Up of Subjects Exposed to GSK3377794 - Mayo Clinic

    About this study. The purpose of this long-term, followup study is to evaluate subjects who have, during the interventional study, received GSK3377794 ...

  6. A Study of Gluten Intolerance in Patients with Diarrhea Predominant Irritable Bowel Syndrome - Mayo Clinic

    About this study. The purpose of this study is to test gluten supplementation for four weeks, to see if it increases small intestinal permeability and ...

  7. https://www.mayoclinic.org/chinese_patient_consumer_video.xml

  8. Study to Evaluate Chemoembolization Combined with Durvalumab and Bevacizumab Therapy in Patients With Locoregional Hepatocellular Carcinoma - Mayo Clinic

    Inclusion Criteria: Male and/or female. Age ≥ 18 years at the time of screening. For patients aged < 20 years and enrolled in Japan, a written informed ...

  9. Post-Operative Mobility after Operative Fixation of Geriatric Distal Femur Fractures - Mayo Clinic

    Inclusion Criteria: Patients ≥ 60 years old who sustain a low energy distal femur fracture (AO-OTA 33A-C) and can give informed consent will be included.

  10. Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With RAS Wild-Type Locally Advanced or Metastatic Colorectal Cancer That Cannot Be Removed by Surgery - Mayo Clinic

    Irinotecan may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as cetuximab and bevacizumab, ...